Newsmax Shares Up 11% at $6.65 After Q4 Results and FY26 Guidance
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 26 2026
0mins
Should l Buy NMAX?
Newsmax up 11% at $6.65 after Q4 results and FY26 guidance
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NMAX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NMAX
Wall Street analysts forecast NMAX stock price to rise
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 6.200
Low
20.00
Averages
20.50
High
21.00
Current: 6.200
Low
20.00
Averages
20.50
High
21.00
About NMAX
Newsmax, Inc. is a holding company that owns 100% of the interests of its operating company, Newsmax Media, Inc. (Newsmax Media). Newsmax Media is a television broadcaster and multi-platform content publisher. Its Broadcast segment of the Company’s business produces and licenses news, business news and lifestyle content for distribution primarily through multichannel video programming distributors (MVPDs), including cable television systems, direct broadcast satellite operators and telecommunication companies, primarily in the United States. The Digital segment includes online advertising, including online display, email advertising, other online placements and print advertisements, subscriptions, including a collection of specialized health and financial newsletters, Newsmax Magazine and four online membership programs, and e-commerce, through its subsidiaries that sell nutraceuticals and nonfiction books on political, financial and health-related topics.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Newsmax Stock Plummets 12.3% Amid Market Volatility
- Stock Volatility: Newsmax's share price fell 12.3% in March, contrasting with a 5.1% decline in the S&P 500 and a 4.8% drop in the Nasdaq Composite, indicating the company's vulnerability amid market turbulence.
- Board Changes Raise Concerns: On March 23, Newsmax appointed Dave Evans to its board and audit committee; while it's uncertain if this triggered the sell-off, investor fears regarding financial reporting and internal controls likely intensified selling pressure.
- Earnings Report Missed Expectations: The company's Q4 earnings report on March 26 revealed revenue of $52.2 million, surpassing Wall Street estimates by approximately $8.2 million, yet a net loss of $3 million did not alleviate valuation concerns, leading to continued stock declines post-report.
- Optimistic Sales Outlook: Newsmax anticipates full-year sales for 2026 between $212 million and $216 million, reflecting an annual growth of about 13%, and expects improved operating profits, suggesting long-term growth potential despite short-term stock pressures.
See More
Newsmax Stock Declines Following Board Appointment and Q4 Report
- Board Appointment Impact: Newsmax's stock declined following the appointment of Dave Evans to the board and audit committee, raising investor concerns about potential issues with financial reporting and internal controls.
- Q4 Earnings Highlights: The company reported Q4 revenue of $52.2 million, exceeding Wall Street estimates by $8.2 million, yet still posted a net loss of $3 million, indicating improved profitability.
- Market Performance Volatility: In March, Newsmax shares fell by 12.3%, contrasting with a 5.1% decline in the S&P 500 and a 4.8% drop in the Nasdaq, highlighting its relative weakness in the market.
- Future Sales Outlook: The company anticipates full-year sales for 2026 to range between $212 million and $216 million, representing an annual growth rate of approximately 13%, suggesting optimism for future growth despite current stock performance challenges.
See More
NEWSMAX STOCK INCREASES 4% FOLLOWING RISE IN Q4 REVENUE
- Company Performance: Newsmax shares increased by 4% following a rise in revenue for the fourth quarter.
- Financial Results: The revenue growth indicates a positive financial performance for the company in the recent quarter.
See More
AstraZeneca's Drug Trial Shows Promising Results
- Drug Trial Success: AstraZeneca's experimental drug tozorakimab significantly reduced flare-ups in chronic obstructive pulmonary disease cases, leading to a 3% stock increase, with full results expected at an upcoming medical meeting, potentially enhancing the company's competitive edge in respiratory medications.
- Travel Platform Upgrade: Tripadvisor's stock rose 3% after Bank of America upgraded its rating from neutral to buy, citing accelerating activist engagement and rising strategic optionality across its portfolio, reflecting market confidence in its future growth prospects.
- Construction Firm Earnings Beat: Argan's stock surged over 10.5% after reporting fourth-quarter earnings of $3.47 per share and revenue of $262.1 million, both exceeding analyst expectations, indicating strong performance in the construction sector that may attract more investor interest.
- Game Development Platform Forecast: Unity Software's stock jumped over 11% after issuing preliminary first-quarter adjusted EBITDA guidance of $130 million to $135 million, surpassing previous guidance of $105 million to $110 million, suggesting ongoing growth potential in the game development industry.
See More
Newsmax Reports 12.6% Revenue Growth in Q4 2025
- Significant Revenue Growth: Newsmax reported total revenues of $52.2 million for Q4 2025, reflecting a 9.6% year-over-year increase and surpassing analysts' expectations of $44 million, which bolstered investor confidence in the company's performance during a non-election year.
- Broadcast Revenue Increase: The company's broadcasting revenues grew 12.6% year-over-year to $42.5 million, driven by affiliate fee revenue growth, increased advertising pricing, and licensing revenue, indicating a robust profitability capacity in a competitive market.
- Strong Financial Position: As of December 31, 2025, Newsmax had $131.3 million in cash and short-term investments, including $20.4 million in cash and $110.9 million in short-term investments, showcasing enhanced financial flexibility following its transition to a public company.
- Optimistic Future Outlook: Newsmax anticipates full-year revenue between $212 million and $216 million for 2026, representing a 13% year-over-year growth, with executives emphasizing a focus on sustainable investments in content, technology, and distribution to support long-term shareholder value.
See More
Newsmax Q4 Revenue Exceeds Expectations
- Strong Revenue Performance: Newsmax reported Q4 revenue of $52.2 million, exceeding market expectations by $8.21 million, indicating robust growth in advertising and content sales despite ongoing profitability challenges.
- Narrowed Net Loss: The company reported a net loss of $3.0 million, an improvement from the $6.9 million loss in the same quarter last year, primarily driven by strategic investments in programming and production capabilities, although ongoing cost pressures remain a concern.
- Decline in Adjusted EBITDA: The adjusted EBITDA was $(1.3) million, a decrease of $(3.8) million from the previous year, reflecting increased production and programming expenses along with rising personnel costs, highlighting financial challenges during the company's expansion.
- Healthy Cash Position: At the end of the quarter, Newsmax held $131.3 million in cash and short-term investments, with $20.4 million in cash and cash equivalents and $110.9 million in short-term investments, ensuring financial flexibility for future investments and operations.
See More
Newsmax Stock Plummets 12.3% Amid Market Volatility
- Stock Volatility: Newsmax's share price fell 12.3% in March, contrasting with a 5.1% decline in the S&P 500 and a 4.8% drop in the Nasdaq Composite, indicating the company's vulnerability amid market turbulence.
- Board Changes Raise Concerns: On March 23, Newsmax appointed Dave Evans to its board and audit committee; while it's uncertain if this triggered the sell-off, investor fears regarding financial reporting and internal controls likely intensified selling pressure.
- Earnings Report Missed Expectations: The company's Q4 earnings report on March 26 revealed revenue of $52.2 million, surpassing Wall Street estimates by approximately $8.2 million, yet a net loss of $3 million did not alleviate valuation concerns, leading to continued stock declines post-report.
- Optimistic Sales Outlook: Newsmax anticipates full-year sales for 2026 between $212 million and $216 million, reflecting an annual growth of about 13%, and expects improved operating profits, suggesting long-term growth potential despite short-term stock pressures.
See More
Newsmax Stock Declines Following Board Appointment and Q4 Report
- Board Appointment Impact: Newsmax's stock declined following the appointment of Dave Evans to the board and audit committee, raising investor concerns about potential issues with financial reporting and internal controls.
- Q4 Earnings Highlights: The company reported Q4 revenue of $52.2 million, exceeding Wall Street estimates by $8.2 million, yet still posted a net loss of $3 million, indicating improved profitability.
- Market Performance Volatility: In March, Newsmax shares fell by 12.3%, contrasting with a 5.1% decline in the S&P 500 and a 4.8% drop in the Nasdaq, highlighting its relative weakness in the market.
- Future Sales Outlook: The company anticipates full-year sales for 2026 to range between $212 million and $216 million, representing an annual growth rate of approximately 13%, suggesting optimism for future growth despite current stock performance challenges.
See More
NEWSMAX STOCK INCREASES 4% FOLLOWING RISE IN Q4 REVENUE
- Company Performance: Newsmax shares increased by 4% following a rise in revenue for the fourth quarter.
- Financial Results: The revenue growth indicates a positive financial performance for the company in the recent quarter.
See More
AstraZeneca's Drug Trial Shows Promising Results
- Drug Trial Success: AstraZeneca's experimental drug tozorakimab significantly reduced flare-ups in chronic obstructive pulmonary disease cases, leading to a 3% stock increase, with full results expected at an upcoming medical meeting, potentially enhancing the company's competitive edge in respiratory medications.
- Travel Platform Upgrade: Tripadvisor's stock rose 3% after Bank of America upgraded its rating from neutral to buy, citing accelerating activist engagement and rising strategic optionality across its portfolio, reflecting market confidence in its future growth prospects.
- Construction Firm Earnings Beat: Argan's stock surged over 10.5% after reporting fourth-quarter earnings of $3.47 per share and revenue of $262.1 million, both exceeding analyst expectations, indicating strong performance in the construction sector that may attract more investor interest.
- Game Development Platform Forecast: Unity Software's stock jumped over 11% after issuing preliminary first-quarter adjusted EBITDA guidance of $130 million to $135 million, surpassing previous guidance of $105 million to $110 million, suggesting ongoing growth potential in the game development industry.
See More
Newsmax Reports 12.6% Revenue Growth in Q4 2025
- Significant Revenue Growth: Newsmax reported total revenues of $52.2 million for Q4 2025, reflecting a 9.6% year-over-year increase and surpassing analysts' expectations of $44 million, which bolstered investor confidence in the company's performance during a non-election year.
- Broadcast Revenue Increase: The company's broadcasting revenues grew 12.6% year-over-year to $42.5 million, driven by affiliate fee revenue growth, increased advertising pricing, and licensing revenue, indicating a robust profitability capacity in a competitive market.
- Strong Financial Position: As of December 31, 2025, Newsmax had $131.3 million in cash and short-term investments, including $20.4 million in cash and $110.9 million in short-term investments, showcasing enhanced financial flexibility following its transition to a public company.
- Optimistic Future Outlook: Newsmax anticipates full-year revenue between $212 million and $216 million for 2026, representing a 13% year-over-year growth, with executives emphasizing a focus on sustainable investments in content, technology, and distribution to support long-term shareholder value.
See More
Newsmax Q4 Revenue Exceeds Expectations
- Strong Revenue Performance: Newsmax reported Q4 revenue of $52.2 million, exceeding market expectations by $8.21 million, indicating robust growth in advertising and content sales despite ongoing profitability challenges.
- Narrowed Net Loss: The company reported a net loss of $3.0 million, an improvement from the $6.9 million loss in the same quarter last year, primarily driven by strategic investments in programming and production capabilities, although ongoing cost pressures remain a concern.
- Decline in Adjusted EBITDA: The adjusted EBITDA was $(1.3) million, a decrease of $(3.8) million from the previous year, reflecting increased production and programming expenses along with rising personnel costs, highlighting financial challenges during the company's expansion.
- Healthy Cash Position: At the end of the quarter, Newsmax held $131.3 million in cash and short-term investments, with $20.4 million in cash and cash equivalents and $110.9 million in short-term investments, ensuring financial flexibility for future investments and operations.
See More
